Table 2.
Predictors of mortality among TB patients treated at DRH from January 2006 – December 2010
| Variables | Status | Adjusted hazard ratio (95 % CI) | p-value | |
|---|---|---|---|---|
| Censored | Died | |||
| Gender | ||||
| Male | 727 | 54 | 1 | |
| Female | 416 | 63 | 2.360 (1.518, 3.671)a | 0.000 |
| Age group | ||||
| < 20 | 129 | 34 | 1 | |
| 20–29 | 366 | 32 | 1.317 (0.629, 2.755) | 0.465 |
| 30–39 | 401 | 21 | 0.335 (0.156, 0.722)a | 0.005 |
| 40–49 | 120 | 17 | 1.029 (0.442, 2.394) | 0.948 |
| > 49 | 127 | 13 | 1.687 (0.649, 4.385) | 0.283 |
| Residence | ||||
| Urban | 1114 | 92 | 1 | |
| Rural | 29 | 25 | 4.230 (2.508, 7.136)a | 0.000 |
| Baseline weight | ||||
| < 20 | 54 | 20 | 1 | |
| 20–29 | 19 | 0 | 0.000 (0.000, 0.000) | 0.957 |
| 30–39 | 99 | 9 | 1.103 (0.420, 2.894) | 0.843 |
| 40–49 | 291 | 40 | 0.811 (0.332, 1.980) | 0.646 |
| > 49 | 680 | 48 | 0.389 (0.178, 0.851)a | 0.018 |
| HIV status | ||||
| Positive | 516 | 113 | 1 | |
| Negative | 627 | 4 | 0.010 (0.003, 0.027)a | 0.000 |
| CPT initiated | ||||
| No | 688 | 79 | 1 | |
| Yes | 455 | 38 | 0.234 (0.145, 0.377)a | 0.000 |
| ART initiated | ||||
| No | 891 | 88 | 1 | |
| Yes | 252 | 29 | 0.694 (0.414, 1.163) | 0.166 |
| Type of TB | ||||
| Smear positive | 192 | 15 | 1 | |
| Smear negative | 472 | 30 | 0.417 (0.207, 0.837)a | 0.014 |
| EPTB | 479 | 72 | 1.149 (0.595, 2.222) | 0.679 |
| Treatment category | ||||
| New | 944 | 109 | 1 | |
| Retreatment | 199 | 8 | 0.438 (0.191, 1.005) | 0.051 |
CPT Cotrimoxazole preventive therapy, ART-Antiretroviral therapy, TB Tuberculosis, EPTB Extrapulmonary TB
aSignificant at α = 0.05